148 related articles for article (PubMed ID: 33849838)
1. [Speckle-type POZ protein up-regulates c-Jun protein expression and promotes proliferation and invasion of renal carcinoma cells].
Wu L; Yu K; Cue Y; Zhu X; Yang Z; Ma J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):447-452. PubMed ID: 33849838
[TBL] [Abstract][Full Text] [Related]
2. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.
Chen Z; Li Z; Li C; Li B; Wang H; Nong D; Li X; Huang G; Lin J; Li W
BMC Cancer; 2022 Dec; 22(1):1277. PubMed ID: 36474188
[TBL] [Abstract][Full Text] [Related]
3. Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
Shi J; Cao J; Lu X; Fan L; Guo H; Fu J
Med Sci Monit; 2021 Apr; 27():e929199. PubMed ID: 33872295
[TBL] [Abstract][Full Text] [Related]
4. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
Zhang XJ; Jin Y; Song JL; Deng F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
[TBL] [Abstract][Full Text] [Related]
5. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
6. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
[TBL] [Abstract][Full Text] [Related]
7. SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
Zeng C; Wang Y; Lu Q; Chen J; Zhang J; Liu T; Lv N; Luo S
J Exp Clin Cancer Res; 2014 Sep; 33(1):75. PubMed ID: 25204354
[TBL] [Abstract][Full Text] [Related]
8. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
[TBL] [Abstract][Full Text] [Related]
9. Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer.
Zhang S; Xiao J; Chai Y; Hong Z; Liu Z; Yuan R; Luo Z; Zhou X; Lucero-Prisno DE; Huang K
Dig Dis Sci; 2018 Feb; 63(2):395-402. PubMed ID: 29260353
[TBL] [Abstract][Full Text] [Related]
10. BTB/POZ domain of speckle-type POZ protein (SPOP) confers proapoptotic function in HeLa cells.
Byun B; Tak H; Joe CO
Biofactors; 2007; 31(3-4):165-9. PubMed ID: 18997279
[TBL] [Abstract][Full Text] [Related]
11. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
[TBL] [Abstract][Full Text] [Related]
12. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.
Wang L; Wei WQ; Wu ZY; Wang GC
Mol Biosyst; 2017 Nov; 13(12):2564-2573. PubMed ID: 29019371
[TBL] [Abstract][Full Text] [Related]
14. Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma.
Chauhan A; Bhattacharyya S; Ojha R; Mandal AK; Singh SK
J Cancer Res Ther; 2018; 14(5):977-982. PubMed ID: 30197334
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer.
Guo ZQ; Zheng T; Chen B; Luo C; Ouyang S; Gong S; Li J; Mao LL; Lian F; Yang Y; Huang Y; Li L; Lu J; Zhang B; Zhou L; Ding H; Gao Z; Zhou L; Li G; Zhou R; Chen K; Liu J; Wen Y; Gong L; Ke Y; Yang SD; Qiu XB; Zhang N; Ren J; Zhong D; Yang CG; Liu J; Jiang H
Cancer Cell; 2016 Sep; 30(3):474-484. PubMed ID: 27622336
[TBL] [Abstract][Full Text] [Related]
16. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
17. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
18. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]